Short Summary
The PTAB held that Apple’s wearable physiological measurement claims were obvious over prior‑art pulse‑oximetry references, rendering all challenged claims unpatentable. The decision relied on Lisogurski, Carlson, and Mannheimer teachings.
Detailed Summary
In IPR2019‑00916 concerning U.S. Patent No. 9,651,533 B2, the Patent Trial and Appeal Board affirmed the institution of the review and subsequently found claims 5, 7‑10, 13, and 15‑17 unpatentable under 35 U.S.C. §103(a). The Board concluded that the combination of Lisogurski’s wearable physiological monitoring system, Carlson’s LED pulsing techniques for improving signal‑to‑noise ratio, and Mannheimer’s spaced detector configuration rendered the asserted claim limitations obvious to a person of ordinary skill in the art. All challenged claims were therefore cancelled, leaving the patent unenforceable.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in SAMSUNG ELECTRONICS CO., LTD. et al. vs OMNI MEDSCI, INC. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Apple Inc.vsAvant Location Technologies LLC
Apple has filed an IPR petition seeking to invalidate Avant’s ’621 patent covering mobile‑presence monitoring, arguing that all 18 claims are obvious over prior art such as Putkiranta, Kraufvelin, Granberg, and Rachabathuni.
Volex plcvsCREDO TECHNOLOGY GROUP LTD.
Volex and Credo Technology Group settled their IPR disputes, leading the PTAB to terminate the proceedings before trial and keep the settlement confidential.
Imperative Care, Inc.vsInari Medical, Inc. et al.
The USPTO granted institution for several Inter Partes Review proceedings after petitioners demonstrated a reasonable likelihood of prevailing on their challenges. Other cases were denied based on discretionary or merits reviews.
Apple Inc.vsMyPort Technologies, Inc.
Court decision.
Carbyne, Inc. et al.vsTritech Software Systems et al.
Carbyne’s request to rehear the PTAB Director’s decision de‑instituting its IPR is challenged by the patent owner, who argues the request merely repeats already‑rejected arguments and violates rehearing standards. The response cites the Revvo and Tesla precedents to support the denial of the rehearing.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.